Login / Signup
Jing Guo
ORCID
Publication Activity (10 Years)
Years Active: 2021-2023
Publications (10 Years): 3
Top Topics
Metastatic Breast Cancer
Signaling Pathway
Induced Apoptosis
Epithelial Mesenchymal Transition
Top Venues
Oxidative medicine and cellular longevity
Cell death & disease
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Donglin Sun
,
Jing Guo
,
Weifei Liang
,
Yangxiao Chen
,
Xiangqiu Chen
,
Li Wang
Anlotinib Alleviates Renal Fibrosis via Inhibition of the ERK and AKT Signaling Pathways.
Oxidative medicine and cellular longevity
2023 (2023)
Donglin Sun
,
Jing Guo
,
Weifei Liang
,
Yangxiao Chen
,
Xiangqiu Chen
,
Li Wang
Anlotinib Alleviates Renal Fibrosis via Inhibition of the ERK and AKT Signaling Pathways.
Oxidative medicine and cellular longevity
2023 (2023)
Jing Guo
,
Xuxian Zhong
,
Qinglin Tan
,
Shengnan Yang
,
Jiaqi Liao
,
Jinke Zhuge
,
Ziyang Hong
,
Qiong Deng
,
Qiang Zuo
miR-301a-3p induced by endoplasmic reticulum stress mediates the occurrence and transmission of trastuzumab resistance in HER2-positive gastric cancer.
Cell death & disease
12 (7) (2021)